Danmei Pang

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

Xichun Hu, Jian Zhang, Binghe Xu et al. · International Journal of Cancer · 2014 · 269 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment

Xi Wang, Shusen Wang, Heng Huang et al. · JAMA · 2020 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Zefei Jiang, Quchang Ouyang, Tao Sun et al. · Nature Medicine · 2024 · 112 citations

Medicine, Oncology, Pharmacology +14

<scp>ARHGAP</scp>42 promotes cell migration and invasion involving <scp>PI</scp>3K/Akt signaling pathway in nasopharyngeal carcinoma

Qian Hu, Xiao Lin, Linxiaoxiao Ding et al. · Cancer Medicine · 2018 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients

Kairong Lin, Danmei Pang, Yabin Jin et al. · Cancer Immunology Immunotherapy · 2018 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17